Literature DB >> 8423887

Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus.

E J Dropcho1, L B Kline, J Riser.   

Abstract

A 45-year-old woman developed opsoclonus, myoclonus, and severe truncal and gait ataxia. Serum and CSF contained IgG antibodies that appear to be identical to "anti-Ri" antibodies associated with paraneoplastic opsoclonus and ataxia. The patient had a fluctuating course with exacerbations that responded well to corticosteroids and later to cyclophosphamide. Her anti-Ri antibody titer has declined significantly but still remains high. After more than 3 years of follow-up, no neoplasm has been detected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423887     DOI: 10.1212/wnl.43.1_part_1.207

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Paraneoplastic Diseases of the Nervous System.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-11       Impact factor: 3.598

3.  Qualitative evidence of anti-Ri specific intrathecal antibody synthesis and quantification of anti-Ri antibodies in serial samples from a patient with anti-Ri syndrome.

Authors:  O Stich; S Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Superficial siderosis of the central nervous system: response to steroid therapy.

Authors:  K Angstwurm; E Schielke; C Zimmer; D Kivelitz; J R Weber
Journal:  J Neurol       Date:  2002-09       Impact factor: 4.849

5.  Paraneoplastic opsoclonus-myoclonus syndrome in metastatic ovarian carcinoma.

Authors:  J Scholz; P Vieregge; C Ruff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

6.  Intermittent Ocular Microflutter in a Patient with Acute-Onset Oscillopsia.

Authors:  Alberto Galvez-Ruiz; Elena Riva-Amarante; Adolfo Jimenez-Huete; Jose Fernandez Lorente; Oriol Franch Ubia
Journal:  Neuroophthalmology       Date:  2017-06-12

7.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

8.  Paraneoplastic brain stem encephalitis.

Authors:  Franz Blaes
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

9.  The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia.

Authors:  Y Y Yang; G L Yin; R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Current Therapies for Paraneoplastic Neurologic Syndromes.

Authors:  Myrna R. Rosenfeld; Josep Dalmau
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.